Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Esophageal Stylet as a Strategy to Minimize the Risk of Esophageal Injury During the Atrial Fibrillation Catheter Ablation Procedure.

NCT02665442 is registered in ClinicalTrials.gov with Northeast Scientific, Inc. as lead sponsor.

NCT NCT02665442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02665442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Esophageal Stylet as a Strategy to Minimize the Risk of Esophageal Injury During the Atrial Fibrillation Catheter Ablation Procedure.
Lead sponsor
Northeast Scientific, Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2016
Completion date
January 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiac arrhythmia, esophageal fistula